Drug Profile
RG 7166
Alternative Names: RG-7166Latest Information Update: 05 Nov 2023
Price :
$50
*
At a glance
- Originator Roche
- Class Antidepressants
- Mechanism of Action Adrenergic uptake inhibitors; Dopamine uptake inhibitors; Serotonin uptake inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Major depressive disorder
Most Recent Events
- 01 Feb 2012 Discontinued - Phase-I for Major depressive disorder (unspecified route)
- 31 Dec 2009 Phase-I clinical trials in Depression (unspecified route)